Fezolinetant

CHEMBL3608680 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

358.4 g/mol

LogP

1.6

Phase

4

A non-hormonal medication that works by blocking neurokinin 3 receptors in the brain to reduce the frequency and severity of hot flashes in postmenopausal women. It provides relief without the use of estrogen, making it an option for those who cannot or prefer not to use hormone therapy.

Moleküler Ağırlık

358,4000 g/mol

LogP

1,60

TPSA

105,00 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Cardiovascular Disease Breast Cancer Prostate Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(F)cc2)[C@@H]3C)n1

InChI

InChI=1S/C16H15FN6OS/c1-9-13-19-20-14(15-18-10(2)21-25-15)23(13)8-7-22(9)16(24)11-3-5-12(17)6-4-11/h3-6,9H,7-8H2,1-2H3/t9-/m1/s1

Molecular Formula

C16H15FN6OS

HBD / HBA

- / 7

Döndürülebilir Bağlar

2

Ağır Atomlar

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A non-hormonal medication that works by blocking neurokinin 3 receptors in the brain to reduce the frequency and severity of hot flashes in postmenopausal women. It provides relief without the use of estrogen, making it an option for those who cannot or prefer not to use hormone therapy.

Yes, Fezolinetant is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3608680. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 117604931. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Fezolinetant PillFYI'da

Yapı

Hızlı Veriler

Formül: C16H15FN6OS
Eş Anlamlılar: 1

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.